SP1 and lung carcinoma: Investigation of the molecular mechanism showed that E2 increases RNF4 expression to reduce Sp1 levels, thereby enhancing CD44 expression through downregulation of several miRNAs, and this leads to a poor prognosis in young women with lung cancer.